Croom Medical, a CDMO specializing in orthopedic implant know-how, launched Biofuse, a 3D printed porous ingrowth platform produced utilizing laser powder mattress fusion (L-PBF) know-how.
Biofuse integrates totally interconnected porous architectures instantly into implant geometries, giving OEMs exact management over pore dimension, porosity, and lattice gradients. By combining dense and porous areas in a single construct, it allows tailor-made ingrowth situations whereas streamlining manufacturing and preserving function constancy.
In contrast to conventional floor therapies akin to spray coating or laser texturing, which offer solely restricted porosity, Biofuse kinds its porous constructions in-built throughout each floor and sub-surface areas. This eliminates delamination dangers, removes coating and machining steps, and ensures structural integrity and constant high quality, even in complicated geometries. The result’s a extra predictable path from design switch via to validated manufacturing, serving to OEMs speed up growth and ship implants with enhanced efficiency.
“Biofuse attracts on our additive expertise, the place we’ve seen firsthand how elements will be each quicker and extra value‑efficient to print than to machine,” stated Sean McConnell, Engineering & NPI Supervisor at Croom Medical. “Embedding lattice constructions instantly into the construct removes coating and machining steps. The result’s a extra predictable manufacturing course of that consolidates manufacturing, preserves structural integrity, and helps OEMs carry implants to market quicker.”
Backed by peer-reviewed research, patents, and ongoing R&D, Biofuse™ is underpinned by Croom Medical’s experience in lattice design and materials behaviour. OEMs can leverage this expertise to duplicate present porous constructions or discover new designs that enhance fixation and manufacturability.
“With Biofuse™, prospects can design lattices to their precise necessities,” stated Dr. Bryan Naab, Additive Lead at Croom Medical. “That may imply replicating a porous construction beforehand produced via coating strategies, or proposing lattice traits. The flexibleness of the platform offers OEMs confidence that their design intent will be realised persistently and in keeping with regulatory expectations.”
Biofuse is now obtainable via Croom Medical’s Additive Manufacturing providing, supporting tasks from early design via to full-scale manufacturing. The launch highlights Croom Medical’s continued funding in additive manufacturing options for orthopedic functions.